AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal

Affiliations

• ¹ Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal; National Public Health Laboratory, Kathmandu, Nepal.
• ² Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal.
• ³ National Public Health Laboratory, Kathmandu, Nepal.
• ⁴ Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
• ⁵ Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
• ⁶ Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, 243 122, India. Electronic address: kdhama@rediffmail.com.
• ⁷ Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de Las Americas, Pereira, Risaralda, Colombia; School of Medicine, Universidad Privada Franz Tamayo (UNIFRANZ), Cochabamba, Bolivia. Electronic address: arodriguezm@utp.edu.co.